APA (7th ed.) Citation

Calvaruso, L., Naticchia, A., Ferraro, P. M., Vischini, G., & Costanzi, S. Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report. Wiley.

Chicago Style (17th ed.) Citation

Calvaruso, Luca, Alessandro Naticchia, Pietro Manuel Ferraro, Gisella Vischini, and Stefano Costanzi. Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report. Wiley.

MLA (9th ed.) Citation

Calvaruso, Luca, et al. Deterioration in Clinical Status Is Not Enough to Suspend Eculizumab: A Genetic Complement-Mediated Atypical Hemolytic Uremic Syndrome Case Report. Wiley.